Reuters logo
BRIEF-Walgreens CFO on conf call- Branded drug price inflation continued, was at a more moderate level
January 5, 2017 / 2:44 PM / in 9 months

BRIEF-Walgreens CFO on conf call- Branded drug price inflation continued, was at a more moderate level

Jan 5 (Reuters) - Walgreens

* CFO on conf call- currency had a negative impact on q1 year-over-year performance, us dollar being around 18% higher versus sterling

* CFO on conf call- branded drug price inflation continued and was at a more moderate level than in prior quarters

* CFO on conf call- Q1 gross margin was higher than last year primarily driven by owned brand performance and procurement benefits

* CFO - recruitment and training of beauty consultants taking slightly longer than expected

* CEO- “no doubt that the (U.S.) healthcare system needs to change by improving the provision of healthcare while acting to control the rapid growth in costs”

* CEO- “Holiday shopping was later than usual, with bulk of sales occurring in the last days before christmas... Once again seen what appears to be a solid holiday period in our main retail market”

* We have been pricing more competitively in some of our networks in preparation to drive volume Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below